AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Progenta breast cancer treatment data presented at cancer research meeting.
2004 MAY 6 - (NewsRx.com & NewsRx.net) -- Zonagen, Inc., (ZONA) announced that data generated at Zonagen in collaboration with scientists at the University of Illinois-Chicago that indicate the potential for Progenta for the treatment of breast cancer were presented at the 2004 Annual Meeting of the American Association for Cancer Research in Orlando, Florida.
Dr. Ronald Wiehle, the company's director of research and development, presented the data. The poster presentation elaborated upon the company's recent finding that Progenta shows significant activity against hormone-dependent breast cancer induced in rats by DMBA.
DMBA is a tumor-inducing agent used in a well-accepted breast cancer tumor model. In the study, rats were given DMBA at 50 days of age and entered randomly into treatment groups when the lead tumor reached 12 mm in size.
Groups of 10 to 13 rats were treated for 28 days with vehicle (oil) or with varying doses of Progenta with or without progesterone. Progenta reduced the size of established tumors significantly and prevented the appearance of new ...
- Two drinks a day increases risk of breast cancer, study shows.
- Magazine article from: Women's Health Weekly March 4, 2004 700+ words
...MD, founder of The Breast Cancer Care & Research...or hopeful time for breast cancer research and treatment...for their particular breast cancer." This article was prepared by Women's Health Weekly editors from staff...
- Irsogladine side-steps angiogenic function to stop breast cancer metastasis.
- Magazine article from: Women's Health Weekly March 25, 2004 700+ words
...agent, irsogladine. Breast Cancer Res Treat, 2004...publisher of the journal Breast Cancer Research and Treatment...Gastroenterology, Oncology, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Change on enzyme gene may associate with invasive disease.(breast cancer...
- Magazine article from: Women's Health Weekly January 9, 2003 700+ words
...than women without breast cancer carried a polymorphism...MMP-3 * Women whose breast cancer had spread were more...metastasis in women with breast cancer This article was prepared by Women's Health Weekly editors from staff...
- Protein tyrosine phosphatase gamma is a tumor suppressor gene in breast cancer.
- Magazine article from: Women's Health Weekly April 1, 2004 700+ words
...independent growth of breast cancer cells in soft agar...PTP gamma) in human breast cancer cell line MCF-7...Enzymology, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- HCCR-2 related to breast cancer development and p53 tumor suppressor regulation.
- Magazine article from: Women's Health Weekly May 6, 2004 700+ words
...Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR...Biotechnology, Oncogenesis and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff and other...
- Older breast cancer patients in Canada benefit from early detection.
- Magazine article from: Women's Health Weekly June 24, 2004 700+ words
...year survival of 2192 breast cancer women diagnosed between...Survival of women with breast cancer in Ottawa, Canada...amp; Mortality, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Gene patterns in the ERBB2/TOP2A region of breast cancer influence outcomes.
- Magazine article from: Women's Health Weekly June 17, 2004 700+ words
...ERBB2/TOP2A region of breast cancer influence outcomes...ERBB2/TOP2A region in breast cancer. Gene Chromosome Cancer...Oncogenesis, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Cystatin M is a novel candidate tumor suppressor gene for breast cancer.
- Magazine article from: Women's Health Weekly December 30, 2004 700+ words
...suppressor gene for breast cancer," Zhang concluded...suppressor gene for breast cancer. Cancer Res, 2004...Suppressor Gene and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- PTEN gene inactivation associates with breast cancer dissemination.
- Magazine article from: Women's Health Weekly February 12, 2004 700+ words
...and progression of breast cancer may not be explained...not angiogenesis, of breast cancer. Pathol Int, 2004...Proteomics, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- COX-2-derived prostaglandin E-2 is a potent breast cancer stimulant.
- Magazine article from: Women's Health Weekly March 11, 2004 700+ words
...prostaglandin E-2 is a potent breast cancer stimulant. "Overexpression...cyclooxygenase 2-induced breast cancer progression. Proc...Enzymology, Oncology, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Source: HighBeam Research, Progenta breast cancer treatment data presented at cancer research...